Harnessing Conventional and Nanotechnology-Enabled Combination Therapies to Combat Kinetoplastid Neglected Tropical Diseases
ACS Infectious Diseases · 11.09.2026 · 12 (9) · 2922-2964
DOI: 10.1021/acsinfecdis.6c00380 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Infectious Diseases, online erschienen am 19.08.2026. Verfasst von Eman Fathi Fadel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Parasitology, Faculty of Medicine, Sohag University, Sohag82524, Egypt. Hauptthemen laut MEDLINE: Neglected Diseases, Leishmaniasis, Antiprotozoal Agents, Nanotechnology. Die Arbeit nennt 198 Literaturangaben.
Abstract (Originalsprache)
The kinetoplastid neglected tropical diseases, Chagas disease, African trypanosomiasis, and leishmaniasis, are vector-borne diseases that remain a persistent global health challenge. Progress has been made in combating human African trypanosomiasis, but efforts to contain other kinetoplastid diseases have been slower. The current drugs used for treatment have limitations, such as drug resistance, toxicity, high cost, and limited access. To overcome these challenges, alternative therapeutic strategies are being explored, including drug combinations, drug repurposing, and nanotechnology, which have shown promise in other diseases, like cancer. Combination therapies, both conventional and nanobased, have the potential to enhance antiparasitic efficacy, reduce side effects, and prevent resistance development. This review focuses on the efficacy and safety of drug combinations for kinetoplastid neglected tropical diseases, highlighting current conventional combination therapies and ongoing research on both conventional and nanobased combination therapies in various stages of development. The review aims to provide novel insights and promote future research for the development of innovative, safe, and effective drug combination therapies. This will help in accelerating progress toward the elimination of Kinetoplastid neglected tropical diseases, in line with Sustainable Development Goal 3.3 to ensure healthy lives and promote well-being for all, at every stage of life and to end the epidemics of neglected tropical diseases by 2030.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Parasitology, Faculty of Medicine, Sohag University, Sohag82524, Egypt.
- Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria21523, Egypt.
ORCID-Profile: Eman Fathi Fadel
Zitieren
APA
Fadel, E. F., & Eissa, M. M. (2026). Harnessing Conventional and Nanotechnology-Enabled Combination Therapies to Combat Kinetoplastid Neglected Tropical Diseases. ACS Infectious Diseases, 12(9), 2922-2964. https://doi.org/10.1021/acsinfecdis.6c00380
Vancouver
Fadel EF, Eissa MM. Harnessing Conventional and Nanotechnology-Enabled Combination Therapies to Combat Kinetoplastid Neglected Tropical Diseases. ACS Infectious Diseases. 2026;12(9):2922-2964. doi:10.1021/acsinfecdis.6c00380
BibTeX
@article{Fadel2026,
author = {Fadel, Eman Fathi and Eissa, Maha M},
title = {Harnessing Conventional and Nanotechnology-Enabled Combination Therapies to Combat Kinetoplastid Neglected Tropical Diseases},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {9},
pages = {2922--2964},
doi = {10.1021/acsinfecdis.6c00380}
}
EUVIMED